ATOSSA THERAPEUTICS I
1.4700
08-十一月-24 14:50:25
15 分钟延时
股票
-0.0300
-2.00%
今日范围
1.4500 - 1.5050
ISIN
N/A
来源
NASDAQ
-
05 11月 2024 07:30:00 条件 Nasdaq GlobeNewswire
-
Atossa Therapeutics Reports Positive KARISMA-Endoxifen Trial Results:
04 11月 2024 05:30:00 条件 Nasdaq GlobeNewswire
-
31 10月 2024 07:15:00 条件 Nasdaq GlobeNewswire
-
21 10月 2024 07:30:00 条件 Nasdaq GlobeNewswire
-
Atossa Therapeutics to Present at the 2024 Maxim Healthcare Virtual Summit
14 10月 2024 16:08:43 条件 Nasdaq GlobeNewswire
-
01 10月 2024 07:30:00 条件 Nasdaq GlobeNewswire
-
Atossa Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference
03 9月 2024 07:30:00 条件 Nasdaq GlobeNewswire
-
Atossa Therapeutics Granted Additional Patent Protection for Endoxifen
28 8月 2024 07:30:00 条件 Nasdaq GlobeNewswire
-
21 8月 2024 07:30:00 条件 Nasdaq GlobeNewswire
-
20 8月 2024 07:30:00 条件 Nasdaq GlobeNewswire
-
Atossa Therapeutics Announces Second Quarter 2024 Financial Results and Provides Corporate Update
12 8月 2024 07:30:00 条件 Nasdaq GlobeNewswire
-
Atossa Therapeutics Appoints Heather Rees as Chief Financial Officer
02 7月 2024 15:15:00 条件 Nasdaq GlobeNewswire
-
28 6月 2024 07:30:00 条件 Nasdaq GlobeNewswire
-
Atossa Set to Join Russell 3000® Index Effective June 28, 2024
17 6月 2024 07:30:00 条件 Nasdaq GlobeNewswire
-
Atossa to Present at the Sidoti Small-Cap Investor Conference
05 6月 2024 07:30:00 条件 Nasdaq GlobeNewswire
-
28 5月 2024 07:30:00 条件 Nasdaq GlobeNewswire
-
15 5月 2024 07:30:00 条件 Nasdaq GlobeNewswire
-
Atossa Therapeutics Announces First Quarter 2024 Financial Results and Provides Corporate Update
13 5月 2024 07:50:00 条件 Nasdaq GlobeNewswire
- <<
- <
- 1
- >